NFKB1 and head and neck squamous cell carcinoma: IKK/NF-κB signaling is a critical pathway that is aberrantly activated in many cancers including HNSCC, promoting expression of mediators of cell proliferation, survival, and therapeutic resistance (4–6, 44).